Healthcare / Medical Care FacilitiesHKSE
$0.48
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $9.1M · quality 43.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
15/100
F
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$192M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-21.1%
↓Gross Margin
84.7%
↑Debt/Equity
0.24
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-29.3%
FCF CAGR
—
FCF margin
47.5%
FCF / Net income
-0.27x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $19.2M · net income $-34.0M · FCF $9.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $19.2M | $19.2M | $26.8M | $45.2M | $54.2M |
| Net Income | $-34.0M | $-34.0M | $-34.2M | $-15.5M | $-29.0M |
| EBITDA | $-27.5M | $-27.5M | $-27.2M | $-16.2M | $-26.9M |
| EPS | -0.09 | -0.09 | -0.09 | -0.04 | -0.07 |
| Gross Margin | 84.7% | 84.7% | 79.1% | 61.8% | 64.2% |
| Operating Margin | -63.0% | -63.0% | -27.4% | -50.5% | -41.7% |
| Net Margin | -177.4% | -177.4% | -127.5% | -34.2% | -53.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.24 | 0.24 | 0.21 | 0.20 | 0.23 |
| Current Ratio | 3.13 | 3.13 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $9.1M | $9.1M | $10.7M | $4.5M | $-31.7M |
| Returns | |||||
| ROE | -21.1% | -21.1% | -17.6% | -6.7% | -12.9% |
| Valuation | |||||
| P/B | 1.19 | 1.19 | 1.07 | 0.88 | 1.96 |
| Growth & Yield | |||||
| Revenue Growth | -28.6% | -28.6% | -40.6% | -16.6% | — |
| EPS Growth | 0.7% | 0.7% | -121.1% | 46.7% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-40.0%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.09 → -0.09
Residual
-40.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.